Know Cancer

or
forgot password

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable Non-Small Cell Lung Cancer (NSCLC) or Metastatic Lung Tumours


Phase 1/Phase 2
18 Years
N/A
Open (Enrolling)
Both
Lung Neoplasms, Lung Cancer

Thank you

Trial Information

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable Non-Small Cell Lung Cancer (NSCLC) or Metastatic Lung Tumours


Inclusion Criteria:



- non-small cell lung cancer less than 6cm; no mediastinal or distant metastases

- Open to Alberta,Canada Residents

Exclusion Criteria:

- tumour size greater than 6cm; inadequate pulmonary function(ie. FEV1 less than 0.8
L), Karnofsky performance status less than 70, multiple co-morbid conditions

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Dose-limiting toxicity as defined by CTCAE V3 grade 4 or 5.

Principal Investigator

Harold P Lau, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Tom Baker Cancer Center

Authority:

Canada: Health Canada

Study ID:

20131

NCT ID:

NCT00351962

Start Date:

September 2006

Completion Date:

Related Keywords:

  • Lung Neoplasms
  • Lung Cancer
  • lung neoplasms
  • metastatic lung cancer
  • stereotactic radiation
  • Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location